Burnham Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
$7.14M Buy
97,041
+50,367
+108% +$3.56M 1.99% 10
2016
Q1
$2.96M Sell
46,674
-2,189
-4% -$138K 0.94% 29
2015
Q4
$3.36M Sell
48,863
-1,189
-2% -$78.6K 0.92% 34
2015
Q3
$2.96M Buy
50,052
+4,400
+10% +$279K 0.78% 38
2015
Q2
$3.04M Buy
45,652
+5,000
+12% +$330K 0.7% 43
2015
Q1
$2.62M Sell
40,652
-2,300
-5% -$144K 0.6% 47
2014
Q4
$2.54M Buy
42,952
+600
+1% +$33.8K 0.58% 45
2014
Q3
$2.17M Buy
42,352
+2,000
+5% +$99.9K 0.48% 63
2014
Q2
$1.96M Buy
40,352
+6,700
+20% +$330K 0.43% 68
2014
Q1
$1.75M Sell
33,652
-1,200
-3% -$63.9K 0.41% 70
2013
Q4
$1.85M Buy
34,852
+4,100
+13% +$209K 0.43% 67
2013
Q3
$1.42M Buy
30,752
+200
+0.7% +$8.78K 0.35% 78
2013
Q2
$1.36M Buy
+30,552
New +$1.33M 0.35% 75

Other funds holding BMY

Burnham Asset Management's BMY Position: Q2 2016 in Review

Burnham Asset Management increased its Bristol-Myers Squibb (BMY) stake by 108% in Q2 2016, buying an estimated $3.56M and bringing the position to 97,041 shares worth $7.14M. The position accounts for 1.99% of the portfolio, ranked #10.

Burnham Asset Management first reported a position in BMY in Q2 2013 and has held it in 13 quarters since. 1,576 funds tracked by Wall St. Rank hold BMY as of Q2 2016.

  • Burnham Asset Management held 97,041 shares of Bristol-Myers Squibb worth $7.14M as of Q2 2016.
  • Burnham Asset Management bought 50,367 Bristol-Myers Squibb shares in Q2 2016, an estimated $3.56M.
  • Bristol-Myers Squibb made up 1.99% of Burnham Asset Management's portfolio in Q2 2016, its #10 holding.
  • Burnham Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 13 quarters since.
  • 1,576 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2016.

Based on Burnham Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.